Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 


A new 2013 research report extends the benefit of BLIS K12™

From: BLIS Technologies Ltd (NZX:BLT)

MediaPak: National Pak

Date: Friday, 11 Dec 2013

Release: Immediate

A new 2013 research report extends the benefit of BLIS K12™ probiotic

BLIS Technologies Ltd (NZX:BLT) announces another clinical study, just published this month, which further supports the effectiveness of BLIS K12™ oral cavity probiotic for preventing ear and throat infections. Published in the medical science journal, Expert Opinion on Biological Therapy, an Italian research team demonstrated that they could prevent the reoccurrence of common ear and throat infections, such as strep throat infection and tonsillitis by more than 83% in adults. The study followed 40 adults with a history of recurrent ear and throat infection and examined the effect of 90 days of treatment with either the BLIS K12™ probiotic or a placebo. Researchers concluded “The regular use of BLIS K12 appears to have effected a substantial reduction in the incidence of recurrent oral streptococcal pathology, reducing the requirement for these BLIS K12-treated individuals to be exposed to therapeutic courses of antibiotics.”

Di Pierro, F., et al. (2013). Clinical evaluation of the oral probiotic Streptococcus salivarius K12 in the prevention of recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes in adults. Expert Opinion on Biological Therapy.

This paper has been published just two months after a similar research paper also concluded that regular use of BLIS K12 in children could reduce the incidence of strep throat infection (including tonsillitis) by more than 92%. The children examined in this earlier study, previously had a recurrence rate for strep throat infection of nearly 4 times per year, however those children who then were assigned to the treatment with the BLIS K12™ probiotic dropped dramatically their rate of infection to the equivalent of just one incidence, every 4 years.

BLIS Technologies CEO, Dr Barry Richardson said, “We have known from our own work over several years about the effectiveness of the BLIS K12™ probiotic in treating and preventing certain infections of the throat and upper airways but finally, we have an independent research group that has now corroborated these findings. It is reassuring to us to know that BLIS K12™ has been independently supported as being highly efficacious in both children and adults.”

Dr Richardson said that he has seen a growing awareness among healthcare professional in New Zealand, pharmacists, dentist and doctors of benefits of BLIS K12™ probiotic for mouth and throat and has seen an increasing acceptance to consider BLIS K12™ probiotic as an option when managing the health of their patients, both young and old.

www.blis.co.nz

ENDS

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Scoop Business: RBNZ Starts Talks On Tougher Rules For Property Speculators

The Reserve Bank of New Zealand is stepping up preparations to restrict lending to residential property investors as it watches house prices, particularly in Auckland, continue to rise strongly. More>>

ALSO:

Research: ‘Ageing Well’ Science Challenge Launched

Science and Innovation Minister Steven Joyce today launched the Ageing Well National Science Challenge, confirming initial funding of $14.6 million. More>>

ALSO:

Scoop Business: Govt Resisting Pressure To Pump More Cash Into Solid Energy

Prime Minister John Key says it is “not the government’s preferred option” to make a fresh capital injection into the troubled state-owned coal miner, Solid Energy, but dodged journalists’ questions at his weekly press conference on whether that might prove necessary... More>>

ALSO:

Lagest Ever Privacy Breach Award: NZCU Baywide Accepts “Severe” Censure In Cake Case

NZCU Baywide says that once it was found to have committed a breach of a former staff member’s privacy, it had attempted to resolve the matter... the censure and remedies for its actions taken almost three years ago are “severe” but accepted, and will hopefully draw a line under the matter. More>>

ALSO:

Scoop Business: PayPal Stops Processing Mega Payments; NZX Listing Still On

PayPal has ceased processing payments for Mega, the file storage and encryption firm looking to join the New Zealand stock market via a reverse listing of TRS Investments, amid claims it is not a legitimate cloud storage service. More>>

ALSO:

Housing Policy: Auckland Densification As Popular As Ebola, English Says

Finance Minister Bill English said calls by the Reserve Bank Governor for more densification in Auckland’s housing were “about as popular in parts of Auckland as Ebola” would be. More>>

ALSO:

Get More From Scoop

 
 
Standards New Zealand

Standards New Zealand
 
 
 
 
 
 
 
 
Business
Search Scoop  
 
 
Powered by Vodafone
NZ independent news